dyceco glp 1 GLP-1 Microdosing How GLP-1 medications are transforming

Smits, M

Front Bioeng Biotechnol

Lillys oral orfoglipron reduces weight in trials Among GLP-1 RAs, only Rybelsus is administered orally

More research will be conducted to see if all GLP-1 drugs carry a similar risk of blood clots and DVT

Essien, MD, MPH, assistant professor of medicine at the University of Pittsburgh School of Medicine and core investigator in the Center for Health Equity and Research Promotion at the VA Pittsburgh Healthcare System, and colleagues wrote that as novel, effective and often costly drugs are approved for use and incorporated into clinical practice guidelines, a disturbing pattern of care is evident: Uptake and diffusion of recommended, evidence-based therapies increase over time, whereas individuals from underrepresented racial and ethnic groups receive these medications less often